Molecular Mechanism of Salvia miltiorrhiza in the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking Technology
Yi-Ling Jiang,Yi Xun
DOI: https://doi.org/10.2147/dddt.s443102
IF: 4.3188
2024-02-13
Drug Design Development and Therapy
Abstract:Yi-Ling Jiang, Yi Xun Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, People's Republic of China Correspondence: Yi Xun, Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, People's Republic of China, Tel +8618773486975, Email Purpose: This study aimed to investigate the effect of Salvia miltiorrhiza on colorectal cancer, as well as the mechanisms involved. Methods: The active compounds of Salvia miltiorrhiza and the associated genes in colorectal cancer were sourced from publicly available databases. Targets associated with colorectal cancer were identified by searching the GeneCards and OMIM databases. Subsequently, the Cytoscape 3.6.0 software was employed to create a regulatory network that illustrates the relationships among active ingredients, colorectal cancer, and their corresponding targets. The String database was utilized to generate a PPI network. Molecular docking studies, conducted with AutoDock Vina, verified the binding capabilities of these active components to core targets. The findings from network pharmacology analysis were corroborated through in vitro experiments. Results: In this study, we identified 39 active components derived from Salvia miltiorrhiza that are predicted to target 544 genes associated with colorectal cancer through network pharmacology. Through a combined analysis of network pharmacology, we isolated three key targets: SRC, IL6, and INS. Molecular docking results convincingly demonstrated Salvia miltiorrhiza 's strong binding affinity to these targets. Additionally, in vitro experiments confirmed that Salvia miltiorrhiza effectively inhibited the progression of colorectal cancer via regulating the INS/SRC/IL6 pathway. Conclusion: Salvia miltiorrhiza emerges as a compelling herbal intervention for colorectal cancer. This study lays the foundation for potential future clinical trials assessing the efficacy of Salvia miltiorrhiza in the management of colorectal cancer. Keywords: Salvia miltiorrhiza , network pharmacology, traditional Chinese medicine, docking technology, colorectal cancer Colorectal cancer is one of the leading causes of death related to cancer worldwide, ranking third and fourth in cancer-related morbidity and mortality, respectively. 1,2 The global burden of colorectal cancer is predicted to increase by 60% by 2030, with 2.2 million new cases and 1.1 million cancer deaths. 3,4 Around 40–50% of colorectal cancer patients will eventually progress to metastatic disease, with approximately 25% of newly diagnosed patients having distant metastasis at the time of diagnosis. 5,6 Moreover, the majority of colorectal cancer patients presented with an advanced stage diagnosis, and it has been reported that the five-year survival rate for individuals diagnosed with colorectal cancer is 14%. 7–9 With a history spanning over 2500 years in China's healthcare system, traditional Chinese medicine boasts a rich heritage. The extensive array of bioactive compounds present in Chinese herbs serves as compelling evidence for their efficacy in managing diverse health conditions. Notably, traditional Chinese medicine has emerged as a promising modality for the treatment of colorectal cancer. 10,11 Salvia miltiorrhiza ranks among the most renowned species within the Salvia genus, which belongs to the Lamiaceae family. 12,13 Salvia miltiorrhiza , first documented in the "Shen-Nong Herbal Classic", is characterized by its bitter taste and slightly cold nature. This herb exhibits properties that promote blood circulation, alleviate blood stasis, provide relief from menstrual pain, cool the blood, and aid in abscess elimination. Clinical and pharmacological studies have shown that Salvia miltiorrhiza has anti-inflammatory and anti-tumor effects. 14–16 However, the precise role of Salvia miltiorrhiza in colorectal cancer and its underlying mechanisms remain elusive, necessitating further investigation. Network pharmacology, as an emerging technology, systematically investigates the potential effects of drugs on diseases by constructing drug-disease-target-pathway interaction networks, thereby providing novel insights into the material basis and mechanism underlying traditional Chinese medicine treatment of diseases. 17,18 The molecular docking method employs computer technology to study the geometric structure and spatial interactions between drug molecules and targets, facilitating the identification of more targeted drugs. 19,20 This study aimed to compre -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal